Skip to main navigation menu Skip to main content Skip to site footer

Pharmacy and pharmacotherapy

July 4, 2025; Zurich, Switzerland: VIII International Scientific and Practical Conference «GRUNDLAGEN DER MODERNEN WISSENSCHAFTLICHEN FORSCHUNG»


THE ROLE OF PROBIOTICS IN MODULATING DRUG BIOAVAILABILITY


DOI
https://doi.org/10.36074/logos-04.07.2025.045
Published
04.07.2025

Abstract

Probiotics are live microorganisms, mainly lactic acid and non-lactic acid bacteria, as well as yeasts, and exhibit various biological activities. Lactobacillus species, such as Lactobacillus rhamnosus and Lactobacillus acidophilus, Bifidobacterium species, including Bifidobacterium bifidum and Bifidobacterium lactis, as well as Saccharomyces boulardii (a probiotic yeast) are known as common probiotic strains.

References

  1. Asogwa, F. K., Ajaghaku, D. L., Asogwa, A. O., Ugwu, C. O., Ikpechukwu, D. M., Ndu, K. C., & Nsude, L. O. (2025). Exploring the potential impact of the use of probiotics on the pharmacokinetics and the pharmacodynamics of drugs: A narrative review. International Journal of Pathogen Research, 14(3), 112–122. https://doi.org/10.9734/ijpr/2025/v14i330392
  2. Baral, K. C., Bajracharya, R., Lee, S. H., & Han, H. K. (2021). Advancements in the pharmaceutical applications of probiotics: Dosage forms and formulation technology. International Journal of Nanomedicine, 16, 7535–7556. https://doi.org/10.2147/IJN.S337427
  3. Purdel, C., Ungurianu, A., Adam-Dima, I., & Margină, D. (2023). Exploring the potential impact of probiotic use on drug metabolism and efficacy. Biomedicine & Pharmacotherapy, 161, 114468. https://doi.org/10.1016/j.biopha.2023.114468
  4. Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2021). The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B, 11(7), 1789–1812. https://doi.org/10.1016/j.apsb.2020.09.013